Save your place

Sign in to WhoBought

Please try again later.

Ray Dalio's Cardinal Health, Inc. (CAH) position

Yes: as of Q1 2026, Ray Dalio holds 115K shares of CAH worth $24M (0.1% of the disclosed portfolio). Held since at least Q1 2021; that opening coverage snapshot is not counted as a purchase.
View full portfolio →
Current value
$24M
Shares held
115K
% of portfolio
0.1%
Est. average buy price (i)
$132.36
est. since Q1 2021
Quarter-end price
$211.31

Estimated trade prices

Average price in quarters with purchases
$89.44
Average prices in quarters with sales
  • Q1 2026: $215.43 (101K shares sold)
  • Q4 2025: $188.23 (55K shares sold)
  • Q1 2025: $127.47 (336K shares sold)
  • Q4 2024: $116.75 (57K shares sold)
  • Q3 2024: $104.55 (6K shares sold)
  • Q2 2024: $101.90 (81K shares sold)
  • Q4 2023: $99.22 (43K shares sold)
  • Q1 2023: $75.45 (31K shares sold)
  • Q3 2022: $63.39 (447K shares sold)

CAH price vs Dalio's position

Dates
$40$100$150$200$25020222023202420252026Added 10K shares (3.5%) · Q3 2021. Average closing price $54.25 · Price range $49.46–$59.9910KsharespurchasedAdded 29K shares (9.9%) · Q4 2021. Average closing price $49.05 · Price range $45.87–$52.1729KsharespurchasedAdded 84K shares (26.0%) · Q1 2022. Average closing price $53.56 · Price range $50.56–$57.9684KsharespurchasedAdded 106K shares (25.8%) · Q2 2022. Average closing price $56.83 · Price range $50.48–$63.86106KsharespurchasedSold 447K shares (86.8%) · Q3 2022. Average closing price $63.39 · Price range $52.25–$71.32447KsharessoldAdded 172K shares (253.1%) · Q4 2022. Average closing price $75.98 · Price range $67.86–$80.98172KsharespurchasedSold 31K shares (12.9%) · Q1 2023. Average closing price $75.45 · Price range $69.01–$79.9231KsharessoldAdded 81K shares (38.8%) · Q2 2023. Average closing price $84.47 · Price range $76.66–$94.5781KsharespurchasedAdded 171K shares (59.0%) · Q3 2023. Average closing price $90.40 · Price range $85.37–$94.63171KsharespurchasedSold 43K shares (9.2%) · Q4 2023. Average closing price $99.22 · Price range $86.38–$108.0543KsharessoldAdded 133K shares (31.8%) · Q1 2024. Average closing price $107.90 · Price range $102.62–$115.62133KsharespurchasedSold 81K shares (14.6%) · Q2 2024. Average closing price $101.90 · Price range $94.75–$112.0681KsharessoldSold 6K shares (1.2%) · Q3 2024. Average closing price $104.55 · Price range $93.74–$114.666KsharessoldSold 57K shares (12.1%) · Q4 2024. Average closing price $116.75 · Price range $107.89–$125.3357KsharessoldSold 336K shares (82.3%) · Q1 2025. Average closing price $127.47 · Price range $118.02–$137.77336KsharessoldAdded 186K shares (258.0%) · Q2 2025. Average closing price $148.41 · Price range $125.00–$168.00186KsharespurchasedAdded 13K shares (5.1%) · Q3 2025. Average closing price $154.47 · Price range $146.04–$167.6313KsharespurchasedSold 55K shares (20.4%) · Q4 2025. Average closing price $188.23 · Price range $153.27–$213.7355KsharessoldSold 101K shares (46.8%) · Q1 2026. Average closing price $215.43 · Price range $201.11–$229.88101Ksharessold← Earlier —1 purchase
Average closing price · filing quarter
$215.43
Price range · filing quarter
$201.11 – $229.88

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Reduced −101K −$22M −46.8% 115K May 15, 2026
Q4 2025 Reduced −55K −$10M −20.4% 217K Feb 13, 2026
Q3 2025 Added +13K +$2.1M +5.1% 272K Nov 13, 2025
Q2 2025 Added +186K +$28M +258.0% 259K Aug 13, 2025
Q1 2025 Reduced −336K −$43M −82.3% 72K May 14, 2025
Q4 2024 Reduced −57K −$6.6M −12.1% 409K Feb 13, 2025
Q3 2024 Reduced −6K −$581K −1.2% 465K Nov 13, 2024
Q2 2024 Reduced −81K −$8.2M −14.6% 471K Aug 14, 2024
Q1 2024 Added +133K +$14M +31.8% 551K May 14, 2024
Q4 2023 Reduced −43K −$4.2M −9.2% 418K Feb 14, 2024
Q3 2023 Added +171K +$15M +59.0% 461K Nov 13, 2023
Q2 2023 Added +81K +$6.8M +38.8% 290K Aug 11, 2023
Q1 2023 Reduced −31K −$2.3M −12.9% 209K May 12, 2023
Q4 2022 Added +172K +$13M +253.1% 240K Feb 13, 2023
Q3 2022 Reduced −447K −$28M −86.8% 68K Nov 10, 2022
Q2 2022 Added +106K +$6.0M +25.8% 515K Aug 11, 2022
Q1 2022 Added +84K +$4.5M +26.0% 409K May 13, 2022
Q4 2021 Added +29K +$1.4M +9.9% 325K Feb 14, 2022
Q3 2021 Added +10K +$539K +3.5% 295K Nov 12, 2021
Q2 2021 Added +121K +$7.1M +73.9% 285K Aug 13, 2021
Q1 2021 First covered 164K May 14, 2021
Data through Q1 2026 · filed May 15, 2026
21 grouped rows from 21 quarters

More Dalio positions

Common questions

Does Ray Dalio own CAH?

Yes. As of Q1 2026, Ray Dalio disclosed 115K shares of CAH, worth $24M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Ray Dalio buy CAH?

Ray Dalio held CAH since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Ray Dalio sell CAH?

The quarter-by-quarter table above shows each sale and reduction Ray Dalio disclosed in CAH. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of CAH does Ray Dalio own?

Ray Dalio disclosed 115K shares of CAH as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Ray Dalio pay for CAH?

Ray Dalio began building the CAH position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.